参考文献/References:
[1] Brazinova A, Rehorcikova V, Taylor MS, et al. Epidemiology of traumatic brain injury in Europe: a living systematic review [J]. J Neurotrauma, 2021, 38(10): 1411-1440.
[2] Hutchinson PJ, Kolias AG, Tajsic T, et al. Consensus statement from the International Consensus Meeting on the Role of Decompressive Craniectomy in the Management of Traumatic Brain Injury : consensus statement [J]. Acta Neurochir (Wien), 2019, 161(7): 1261-1274.
[3] Kim JH, Ahn JH, Oh JK, et al. Factors associated with the development and outcome of hydrocephalus after decom-pressive craniectomy for traumatic brain injury [J]. Neuro-surg Rev, 2021, 44(1): 471-478.
[4] 中华医学会创伤学分会颅脑创伤专业委员会. 颅脑创伤病人脑脊液管理中国专家共识[J]. 中华神经外科杂志,2019,35(8):760-764.
[5] 中国医师协会神经外科医师分会,中国神经创伤专家委员会. 中国颅脑创伤外科手术指南[J]. 中华神经创伤外科电子杂志,2015,1(1):59-60.
[6] Chen KH, Lee CP, Yang YH, et al. Incidence of hydrocephalus in traumatic brain injury: a nationwide population-based cohort study [J]. Medicine (Baltimore), 2019, 98(42): e17568.
[7] Chen S, Luo J, Reis C, et al. Hydrocephalus after subarachnoid hemorrhage: pathophysiology, diagnosis, and treatment [J]. Biomed Res Int, 2017, 2017: 8584753.
[8] 刘 彤,何沛邦,李明昌. 特发性正常压力脑积水发病机制的研究新进展[J]. 中国临床神经外科杂志,2021,26(2):133-136.
[9] Yang H, Wang H, Andersson U. Targeting inflammation driven by HMGB1 [J]. Front Immunol, 2020, 11: 484.
[10] Volchuk A, Ye A, Chi L, et al. Indirect regulation of HMGB1release by gasdermin D [J]. Nat Commun, 2020, 11(1): 4561.
[11] Paudel YN, Angelopoulou E, Piperi C, et al. HMGB1-mediated neuroinflammatory responses in brain injuries: potential mechanisms and therapeutic opportunities [J]. Int J Mol Sci, 2020, 21(13): 4609.
[12] Muhammad S, Chaudhry SR, Kahlert UD, et al. Targeting high mobility group box 1 in subarachnoid hemorrhage: a systematic review [J]. Int J Mol Sci, 2020, 21(8): 2709.
[13] Watanabe M, Miyajima M, Nakajima M, et al. Expression analysis of high mobility group box-1 protein (HMGB-1) in the cerebral cortex,hippocampus,and cerebellum of the congenital hydrocephalus (H-Tx) rat [J]. Acta Neurochir Suppl, 2012, 113: 91-96.
[14] Lorente L, Martín MM, Ortiz-López R, et al. Association between serum sFasL concentrations and sepsis mortality [J]. Infect Dis (Lond), 2021, 53(1): 38-43.
[15] Kajikawa O, Herrero R, Chow YH, et al. The bioactivity of soluble Fas ligand is modulated by key amino acids of its stalk region [J]. PLoS One, 2021, 16(6): e0253260.
[16] Lorente L, Martín MM, Pérez-Cejas A, et al. High serum soluble Fas ligand levels in non-survivor traumatic brain injury patients [J]. Neurocrit Care, 2021, 35(1): 249-254.
[17] Felderhoff-Mueser U, Herold R, Hochhaus F, et al. Increased cerebrospinal fluid concentrations of soluble Fas (CD95/Apo-1) in hydrocephalus [J]. Arch Dis Child, 2001, 84(4): 369-372.
[18] Zhong H, Li X, Zhou S, et al. Interplay between RAGE and TLR4 regulates HMGB1-induced inflammation by promoting cell surface expression of RAGE and TLR4 [J]. J Immunol, 2020, 205(3): 767-775.
[19] Felderhoff-Mueser U, Buhrer C, Groneck P, et al. Soluble Fas (CD95/Apo-1),soluble Fas ligand,and activated caspase 3 in the cerebrospinal fluid of infants with posthemorrhagic and nonhemorrhagic hydrocephalus [J]. Pediatr Res, 2003, 54(5): 659-664.
相似文献/References:
[1]张善纲 综述.现代战争中颅脑损伤的特点及功能康复[J].中国临床神经外科杂志,2015,(11):701.[doi:10.13798/j.issn.1009-153X.2015.11.021]
[2]钟秀均 黄书岚.复方醒脑液治疗颅脑损伤后综合征的临床观察[J].中国临床神经外科杂志,2016,(05):278.[doi:10.13798/j.issn.1009-153X.2016.05.007]
ZHONG Xiu-jun,HUANG Shu-lan..Clinical observation on treatment of compound decoction for cerebral prorection for post-traumatic brain syndrome[J].,2016,(11):278.[doi:10.13798/j.issn.1009-153X.2016.05.007]
[3]李国亮 邸 方 杨亚东.香芹酚通过抑制脑水肿与氧化应激反应保护大鼠
颅脑损伤[J].中国临床神经外科杂志,2016,(05):283.[doi:10.13798/j.issn.1009-153X.2016.05.009]
LI Guo-liang,DI Fang,YANG Ya-dong..Carvacrol protects against traumatic brain injury in rats through suppressing the brain edma and oxidative stress[J].,2016,(11):283.[doi:10.13798/j.issn.1009-153X.2016.05.009]
[4]罗心凯 陈治标 陈谦学.免缝胶原海绵人工硬脑膜在颅脑损伤大骨瓣减压术中的应用[J].中国临床神经外科杂志,2016,(06):357.[doi:10.13798/j.issn.1009-153X.2016.06.012]
LUO Xin-kai,CHEN Zhi-biao,CHEN Qian-xue..Application of collagen sponge artificial dura without suturing to big bone flap decompression after traumatic brain injury[J].,2016,(11):357.[doi:10.13798/j.issn.1009-153X.2016.06.012]
[5]贺瑛福 肖宗宇 马进海 许常林 裴 杰 袁 岗 张广华 巨 虎.高海拔地区重型颅脑损伤血清FSH、LH、PRL的变化[J].中国临床神经外科杂志,2016,(06):359.[doi:10.13798/j.issn.1009-153X.2016.06.013]
HE Ying-fu,XIAO Zong-yu,MA Jin-hai,et al.Changes in serum FSH, LH and PRL levels in the patients with severe traumatic brain injury in plateau[J].,2016,(11):359.[doi:10.13798/j.issn.1009-153X.2016.06.013]
[6]满明昊 李立宏 杨彦龙 李 敏 郭少春.颅脑损伤术后细胞免疫指标变化及脾多肽对其影响[J].中国临床神经外科杂志,2016,(06):362.[doi:10.13798/j.issn.1009-153X.2016.06.014]
MAN Ming-hao,LI Li-hong,YANG Yan-yong,et al.Changes in peripheral cells immunity after operation and effect of spleen polypeptide on them in patients with traumatic brain injury[J].,2016,(11):362.[doi:10.13798/j.issn.1009-153X.2016.06.014]
[7]程 勇 秦加新 戢翰升 李 刚 聂劲林 李 强.颅脑损伤术中急性脑膨出的相关因素分析[J].中国临床神经外科杂志,2016,(06):374.[doi:10.13798/j.issn.1009-153X.2016.06.019]
[8]张一帆 综述 张国来 审校.弥漫性轴索损伤影像学诊断的研究进展[J].中国临床神经外科杂志,2016,(07):442.[doi:10.13798/j.issn.1009-153X.2016.07.020]
[9]陈吉钢 张丹枫 魏嘉良 邹 伟 侯立军.创伤性眶上裂综合征的治疗陈吉钢[J].中国临床神经外科杂志,2016,(04):200.[doi:10.13798/j.issn.1009-153X.2016.04.003]
CHEN Ji-gang,ZHANG Dan-feng,WEI Jiang-liang,et al.Management of traumatic superior orbital fissure syndrome (report of 22 cases)[J].,2016,(11):200.[doi:10.13798/j.issn.1009-153X.2016.04.003]
[10]肖连福 黄瑞宏 陈昌勇.外伤性颅内静脉窦血栓形成1例[J].中国临床神经外科杂志,2016,(04):256.[doi:10.13798/j.issn.1009-153X.2016.04.024]